Evidence map›Paper›PMID 34976302›Full record

ArticleOxidative medicine and cellular longevity2021

Biological Anti-TNF-

Emőke Šteňová, Martina Bakošová, Lucia Lauková, Peter Celec, Barbora Vlková

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Emőke Šteňová1st Department of Internal Medicine, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia.ORCID https://orcid.org/0000-0001-6595-2959
Martina Bakošová1st Department of Internal Medicine, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia.
Lucia LaukováInstitute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.ORCID https://orcid.org/0000-0002-5705-8137
Peter CelecInstitute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.ORCID https://orcid.org/0000-0001-5883-3580
Barbora VlkováInstitute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.ORCID https://orcid.org/0000-0003-3907-5432
Comenius University Bratislava · SKUniversity Hospital Bratislava · SKUniversität für Weiterbildung Krems · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) as a chronic inflammatory disease is associated with oxidative stress. Drugs targeting tumor necrosis factor-alpha (TNF-

Indexed as

AgedArthritis, RheumatoidFemaleHumansMaleMiddle AgedOxidative StressTumor Necrosis Factor InhibitorsTumor Necrosis Factor Inhibitors

Identifiers

PMID34976302
PMCPMC8716244
OpenAlexW4200179860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.